Oculis Holding AG (OCS) Common Equity (2021 - 2026)
Quarterly Common Equity rose 38.83% to $251.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $251.1 million through Mar 2026, up 38.83% year-over-year, with the annual reading at $245.3 million for FY2025, 192.85% up from the prior year.
Oculis Holding AG's Common Equity history spans 6 years, with the latest figure at $251.1 million for Q1 2026.
- Common Equity came in at $251.1 million for Q1 2026, up from $245.3 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $251.1 million in Q1 2026 to a low of -$101.7 million in Q4 2022.
- The 5-year median for Common Equity is $124.8 million (2024), against an average of $128.9 million.
- Year-over-year, Common Equity plummeted 53.87% in 2022 and then surged 203.88% in 2023.
- Oculis Holding AG's Common Equity stood at -$101.7 million in 2022, then soared by 203.88% to $105.7 million in 2023, then dropped by 20.72% to $83.8 million in 2024, then skyrocketed by 192.85% to $245.3 million in 2025, then grew by 2.37% to $251.1 million in 2026.
- Per Business Quant, the three most recent readings for OCS's Common Equity are $251.1 million (Q1 2026), $245.3 million (Q4 2025), and $163.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.42 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 35.63 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 31.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 13.21 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | 251.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 251.12 Mn |
| Dec 31, 2025 | 245.32 Mn |
| Sep 30, 2025 | 163.26 Mn |
| Jun 30, 2025 | 172.84 Mn |
| Mar 31, 2025 | 180.88 Mn |
| Dec 31, 2024 | 83.77 Mn |
| Sep 30, 2024 | 109.91 Mn |
| Jun 30, 2024 | 124.76 Mn |
| Mar 31, 2024 | 90.55 Mn |
| Dec 31, 2023 | 105.66 Mn |
| Sep 30, 2023 | 119.56 Mn |
| Jun 30, 2023 | 130.34 Mn |
| Dec 31, 2022 | -101.72 Mn |
| Dec 31, 2021 | -66.11 Mn |